Cerebral protection in left atrial appendage closure in the presence of appendage thrombosis
Giacomo Boccuzzi, Andrea Montabone, Fabrizio D’Ascenzo, Francesco Colombo, Fabrizio Ugo, Simone Muraglia, Ole De Backer, Luis Nombela‐Franco, Felix Meincke, Patrizio Mazzone
Abstract
Abstract Background Presence of thrombus in the left atrial appendage (LAA) remains a severe contraindication to the percutaneous left atrial appendage closure procedure (LAAC), due to increased embolic risk. Recently, the experience developed in cerebral protection device in transcatheter aortic valve implantation (TAVI) procedure was translated in LAAC to address this issue. Aim To evaluate efficacy and safety of Sentinel cerebral protection system (CPS) in supporting LAAC in real‐world patient with persistent LAA thrombus. Methods and results The study retrospectively enrolled consecutive patients with non‐valvular atrial fibrillation (NVAF) and thrombus in LAA who underwent LAAC supported by Sentinel CPS in seven European high‐volume centres. Twenty‐seven patients were included with a median age of 69.1 ± 9.7 years old, with median CHA 2 DS 2 ‐VASc and HAS‐BLEED scores 3 [2–5] and 3 [2.75–4], respectively. Technical and procedural success was achieved in all patients. No periprocedural TIA, stroke, or supra‐aortic trunks dissection was recorded. Conclusions In this multicenter registry, LAAC supported by Sentinel CPS in patients with LAA persistent thrombus seems to be a safe and efficacious treatment.